Maxigen Biotech Inc. (1783)
Market Closed
15 Jun, 05:30
TWSE TWSE Primary NT$
39. 00
0
0%
NT$
4B Market Cap
- P/E Ratio
- Div Yield
136,355 Volume
0 Eps
NT$ 39
Previous Close Want to track 1783 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Maxigen Biotech Inc. (1783) Statistics
Valuation metrics
Market Cap 4B
Enterprise value 2.95B
Trailing P/E (ttm) 12.88
Forward P/E -
PEG ratio 0.44
Price/Sales (ttm) 4.24
Price/Book (mrq) 2.15
Enterprise Value/Revenue 3.57
Enterprise Value/EBITDA 9.36
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 127.09K
Average volume (90 days) 115.05K
Price summary
52-Week low 37.8
52-Week high 48.85
Beta -
50-Day moving average 38.96
200-Day moving average 42.47
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate 0.83
Trailing annual dividend yield 0.0213%
5-Year annual dividend yield -
Payout ratio 0.27
Dividend Date 30 Sep 2025
Ex-Dividend Date 5 Sep 2025
Last split factor 1,050:1,000
Last split Date 7 Sep 2023
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin 0.33%
Operating margin 0.32%
Operational effectiveness
Return on assets 0.14%
Return on equity 0.18%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 9.22
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) 3.03
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 10.63
Total debt (mrq) -
Total Debt/Equity (mrq) 0.06
Current ratio (mrq) 3.32%
Book value per share (mrq) 18.18
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
